AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8861437
Drug: Gelseal Vascutek
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelseal Vascutek graft immersed for 15 min in a solution containing 1 mg/ml rifampicin (group A)
Trial: 6147067
Drug: Basal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal therapy (B) with monthly appointments
Trial: 27486681
Drug: Tübingen exercise
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tübingen exercise therapy approach (THüKo)
Trial: 18840133
Drug: Immunohistochemical analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunohistochemical analysis using Ber‐EP4 antibody
Trial: 18840133
Drug: Immunohistochemical analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunohistochemical analysis using AE1/AE3 antibody
Trial: 18840133
Drug: Immunohistochemical analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunohistochemical analysis using CAM 5.2 antibody
Trial: 16504324
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum MF1298
Trial: 16504324
Drug: L. pentosus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. pentosus DC13
Trial: 16504324
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum MF1298 (as sausage)
Trial: 16504324
Drug: L. pentosus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. pentosus DC13 (as sausage)
Trial: 11062570
Drug: Topical lignocaine‐prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lignocaine‐prilocaine anaesthetic cream
Trial: 9258888
Drug: 15 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml/kg of lactated ringer intravenously as prehydration
Trial: 2685045
Drug: Tailored psychological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored psychological treatment of insomnia
Trial: 2685045
Drug: Untailored treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untailored treatment (stimulus control therapy)
Trial: 25572279
Drug: Calmare® treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calmare® treatment (up to 10 sessions)
Trial: 25572279
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (non-therapeutic threshold)
Trial: 25572279
Drug: Calmare® treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calmare® treatment
Trial: 21490695
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (2 g) and E (800 IU)
Trial: 16785153
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (GnRH‐ant)
Trial: 15169798
Drug: Three rF‐PSA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three rF‐PSA vaccines followed by one vaccinia‐PSA (rV‐PSA) vaccine
Trial: 15169798
Drug: One rV‐PSA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One rV‐PSA vaccine followed by three rF‐PSA vaccines
Trial: 15169798
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment with poxviruses expressing PSA
Trial: 9233107
Drug: Timed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timed-dose
Trial: 8425810
Drug: Topical paromomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical paromomycin treatment
Trial: 30356343
Drug: Paracervical injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracervical injection of 0.25% bupivacaine with epinephrine
Trial: 15067655
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 mL normal saline)
Trial: 21951314
Drug: SB‐705498 (TRPV1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB‐705498 (TRPV1 blocker) administered via nasal lavage 2 minutes before each allergen challenge.
Trial: 16192763
Drug: 22.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22.5 mg/kg acetaminophen
Trial: 16192763
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg acetaminophen
Trial: 16192763
Drug: Acetaminophen (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (all doses)
Trial: 9288701
Drug: Estraderm MX
RxNorm normalized name: Estraderm MX
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estraderm MX 50 (0.05 mg estradiol per day)
Trial: 7506145
Drug: Nimesulide (100mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide (100mg twice daily)
Trial: 7506163
Drug: Naproxen (250mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (250mg twice daily)
Trial: 3828183
Drug: 3% 2‐chloroprocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% 2‐chloroprocaine 23 ml administered in head-up position
Trial: 3828183
Drug: 3% 2‐chloroprocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% 2‐chloroprocaine 23 ml administered in supine position
Trial: 29885026
Drug: Telephone-delivered exercise
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-delivered exercise therapy
Trial: 26280247
Drug: Polypill strategy
RxNorm normalized name: POLYPILUS FRONDOSUS WHOLE
DrugBank: Grifola frondosa whole (DB19262)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypill strategy (containing a statin, antiplatelet agent, and two blood-pressure-lowering medications)
Trial: 21823422
Drug: Tangzu Yuyang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tangzu Yuyang Ointment (TYO) plus Standard Wound Therapy (SWT)
Trial: 21823422
Drug: Standard Wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Wound Therapy (SWT)
Trial: 17368881
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) supplementation (2.2 g daily for 8 weeks)
Trial: 14687104
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug administration system
Trial: 9745973
Drug: Midodrine hydrochloride,
RxNorm normalized name: Midodrine Hydrochloride, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine hydrochloride, dosage and duration not specified
Trial: 7818196
Drug: Propacetamol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propacetamol (2 g) combined with nalbuphine hydrochloride (10 mg)
Trial: 7818196
Drug: Nalbuphine hydrochloride
RxNorm normalized name: Nalbuphine Hydrochloride
DrugBank: Nalbuphine (DB00844)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalbuphine hydrochloride (20 mg)
Trial: 31980022
Drug: Flaxseed powder
RxNorm normalized name: Flaxseed Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed powder (30 g/day) plus lifestyle modification
Trial: 30895611
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole (400 mg, three times per day for 7 days)
Trial: 30895611
Drug: Combined vaginal
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined vaginal tablet (nystatin 100,000 U, diiodohydroxyquin 100 mg, benzalkonium chloride 7 mg, once daily for 7 days)
Trial: 30895611
Drug: Combined vaginal
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined vaginal tablet
Trial: 23128968
Drug: Cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol 100 mg twice a day plus aspirin 100 mg a day
Trial: 23128968
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus aspirin 100 mg a day
Trial: 19388074
Drug: Targeted care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted care bundle consisting of medication counseling/reconciliation by a clinical pharmacist, condition specific education/enhanced discharge planning by a care coordinator, and phone follow-up.
Trial: 308770
Drug: Sensory-stimulating treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensory-stimulating treatment for eight weeks
Trial: 28809610
Drug: Cabazitaxel 20
RxNorm normalized name: cabazitaxel 20 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel 20 mg/m2 (C20)
Trial: 28809610
Drug: Cabazitaxel 25
RxNorm normalized name: Cabazitaxel
DrugBank: Cabazitaxel (DB06772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cabazitaxel 25 mg/m2 (C25)
Trial: 15625211
Drug: Clozapine +
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine + Risperidone (up to 6 mg/day)
Trial: 12169075
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (200 mg)
Trial: 8723585
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (150 IU/kg subcutaneously on alternate days; six doses)
Trial: 2054690
Drug: Midazolam 10
RxNorm normalized name: midazolam 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 10 mg intramuscularly
Trial: 2054690
Drug: Diazepam 15
RxNorm normalized name: diazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 15 mg intramuscularly
Trial: 31825024
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education sessions delivered by trained schoolteachers
Trial: 31825024
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no extra oral health education)
Trial: 28120629
Drug: ropinirole PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropinirole PR 8 mg/day
Trial: 28120629
Drug: ropinirole PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropinirole PR 12 mg/day
Trial: 25827078
Drug: Subcutaneous suture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous suture only without subcuticular skin suture (case group, n=68)
Trial: 25827078
Drug: Subcutaneous suture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous suture and subcuticular skin suture (control group, n=70)
Trial: 23873992
Drug: Biological factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological factors (early neonatal mortality)
Trial: 19249945
Drug: Ropinirole (0.25-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirole (0.25-6 mg)
Trial: 16752943
Drug: Hexylaminolevulinate 4
RxNorm normalized name: aminolevulinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexylaminolevulinate 4 mmol/L
Trial: 16752943
Drug: Hexylaminolevulinate 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexylaminolevulinate 8 mmol/L
Trial: 16752943
Drug: Hexylaminolevulinate 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexylaminolevulinate 16 mmol/L
Trial: 14737056
Drug: Humalog (insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Humalog (insulin lispro)
Trial: 11719362
Drug: Orbofiban (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orbofiban (oral GPIIb/IIIa antagonist)
Trial: 15305178
Drug: linoleic acid
RxNorm normalized name: Linoleic acid
DrugBank: Linoleic acid (DB14104)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linoleic acid (L fat)
Trial: 10834505
Drug: Preoperative hypervolaemic
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative hypervolaemic haemodilution using hydroxyethyl starch, followed by intraoperative crystalloid infusion
Trial: 2005168
Drug: Local injections
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local injections of corticosteroid and local anaesthesia
Trial: 2005168
Drug: Manipulation and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manipulation and injection
Trial: 3927764
Drug: Lysine acetylsalicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine acetylsalicylate 1.8 g in 10 ml of saline intravenously
Trial: 3927764
Drug: Placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injection of 10 ml of saline intravenously
Trial: 30203763
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine Kouchuang Xiaotong powder
Trial: 30203763
Drug: General routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General routine treatment
Trial: 24092662
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro mix 75/25 (LM75/25)
Trial: 18044772
Drug: Miconazole 50-mg
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole 50-mg mucoadhesive buccal tablet (MBT)
Trial: 18044772
Drug: Miconazole 500-mg
RxNorm normalized name: Miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole 500-mg oral gel (MOG)
Trial: 12635389
Drug: Midazolam 0.015
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.015 mg/kg i.v.
Trial: 1391062
Drug: Recombinant interferon
RxNorm normalized name: Recombinant Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant interferon gamma (0.1 mg, subcutaneously 3 times a week for 6 weeks)
Trial: 3977198
Drug: Intervention: Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention: Treatment algorithm to increase patient involvement in care during a 20-minute session before a scheduled visit.
Trial: 3977198
Drug: Intervention: Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention: Treatment algorithm to increase patient involvement in care.
Trial: 27965848
Drug: Oral feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral feeding plus pre-treatment gastrostomy tube
Trial: 27965848
Drug: Oral feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral feeding plus as-needed nasogastric tube feeding
Trial: 25217473
Drug: Intranasal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ketamine 2 mg/kg
Trial: 25217473
Drug: Intranasal alfentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal alfentanil 10 µg/kg
Trial: 25217473
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline 1 ml
Trial: 23236769
Drug: Hormone
RxNorm normalized name: Hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone
Trial: 23236769
Drug: XAP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XAP and Hormone
Trial: 23236769
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three groups (XAP, Hormone, XAP and Hormone)
Trial: 23236769
Drug: XAP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XAP and Hormone vs Hormone
Trial: 20078514
Drug: Periprostatic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periprostatic injection of levobupivacaine
Trial: 20078514
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository and levobupivacaine
Trial: 13130389
Drug: EGb 761
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761 (120 mg)
Trial: 9925116
Drug: Lipid infusion
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid infusion (11.97 kJ/min, or 2.86 kcal/min)
Trial: 9925116
Drug: Glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose infusion (11.97 kJ/min)
Trial: 9925116
Drug: Control infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control infusion (saline)
Trial: 2297824
Drug: Intracoronary adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary adenosine infusion
Trial: 2297824
Drug: Aminophylline after
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline after intracoronary adenosine infusion
Trial: 7358209
Drug: Hydroderm ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroderm ointment base (1% hydrocortisone)
Trial: 7358209
Drug: Established hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Established hydrocortisone ointment formulation
Trial: 25283139
Drug: B-vitamins supplementation
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: B-vitamins supplementation (vitamin D3 1200 IU, folic acid 500 μg, vitamin B12 500 μg, vitamin B6 50 mg, calcium carbonate 456 mg)
Trial: 20008251
Drug: DNA methyltransferase
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNA methyltransferase inhibitors
Trial: 16865032
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual delivered by school‐based mental health clinicians (Control)
Trial: 9058688
Drug: Inhaled budesonide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide, 800 microg two times a day
Trial: 2951261
Drug: Doxazosin (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (1, 2, 4, 8 or 16 mg)
Trial: 2951261
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 or 100 mg)
Trial: 27151999
Drug: Psychoanalytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoanalytic therapy (PA)
Trial: 27151999
Drug: Psychodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychodynamic therapy (PD)
Trial: 21040556
Drug: Regular care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular care with individual outpatient consultation with a rheumatologist (treatment as usual)
Trial: 29220542
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg QW
Trial: 11124745
Drug: 10% triacylglycerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% triacylglycerol emulsion infusion
Trial: 9643859
Drug: Zinc lozenges,
RxNorm normalized name: Zinc Lozenges, Vitamin C with Zinc oral lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc lozenges, 10 mg, orally dissolved, 5 times a day (grades 1-6) or 6 times a day (grades 7-12)
Trial: 28494765
Drug: Zinc lozenges
RxNorm normalized name: Zinc Lozenges
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc lozenges
Trial: 8163780
Drug: Medication requirements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication requirements
Trial: 16817279
Drug: Jinsang Liyan
RxNorm normalized name: Lian Fang
DrugBank: Nelumbo nucifera flower (DB14333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jinsang Liyan Wan (Pills for a Good Voice by Relieving Sore‐Throat)
Trial: 14510744
Drug: Oral esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral esomeprazole (40 mg o.d.)
Trial: 14510744
Drug: Intravenous pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pantoprazole (40 mg o.d.)
Trial: 1316307
Drug: Cryotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy plus subcutaneous interferon (IFN) alpha 2a
Trial: 3927805
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of diazepam orally
Trial: 26707354
Drug: Propranolol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (1 mg/kg)
Trial: 22488557
Drug: Glucagon (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucagon (0.5 mg) administered intravenously during endoscopy (GL group)
Trial: 22488557
Drug: Scopolamine butylbromide
RxNorm normalized name: Scopolamine butylbromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine butylbromide (10 mg) administered intravenously during endoscopy (SC group)
Trial: 22488557
Drug: No medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medications used prior to PET (NO group)
Trial: 19757017
Drug: 0.25% UC781
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% UC781 gel
Trial: 21830124
Drug: Verapamil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil infusion
Trial: 9639377
Drug: Other antiarrhythmic
RxNorm normalized name: Other antiarrhythmics, class I and III
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antiarrhythmic drugs (procainamide, propafenone, propranolol, dl-sotalol, amiodarone)
Trial: 9639377
Drug: All antiarrhythmic
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All antiarrhythmic drugs